April 15, 2024
LIPUS-Brain pivotal trial for patients with early-stage Alzheimer’s disease has been implemented at 19 sites nationwide
The clinical trial for a validation study to evaluate the efficacy and safety of the LIPUS-Brain transcranial low-power pulsed wave ultrasound device for patients with early-stage Alzheimer’s disease is being conducted at 19 facilities nationwide, including Fukuoka Sanno Hospital and Niigata University Medical and Dental Hospital, in addition to the originally planned 17 facilities.
For details of the clinical trial, please refer to the Clinical Trial Information page.
Clinical Trial Information
【Inquiries about clinical trials】
Please contact us using the dedicated form.
Please note that we are not able to introduce or recommend facilities.